CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Anhui Anke Biotechnology (Group) Company., Limited Company Snapshot
Anhui Anke Biotechnology (Group) Company., Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Anhui Anke Biotechnology (Group) Company., Limited with three other companies in this sector in China: Yipinhong Pharmaceutical Co Ltd (2018 sales of 1.43 billion Chinese Renmimbi [US$203.27 million] of which 67% was Pharmaceutical Manufacturing), Shanghai Kaibao Pharmaceutical Company Limited (1.50 billion Chinese Renmimbi [US$213.38 million] of which 100% was Industrial), and Beijing Science Sun Pharmaceutical Co Ltd (1.43 billion Chinese Renmimbi [US$203.01 million] of which 54% was Immune system medication).

Sales Analysis. During the year ended December of 2018, sales at Anhui Anke Biotechnology (Group) Company., Limited were 1.46 billion Chinese Renmimbi (US$207.82 million). This is an increase of 33.3% versus 2017, when the company's sales were 1.10 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Anhui Anke Biotechnology (Group) Company., Limited (and since 2013, sales have increased a total of 240%). Sales of Medicine saw an increase that was more than double the company's growth rate: sales were up 101.6% in 2018, from 217.54 million Chinese Renmimbi to 438.64 million Chinese Renmimbi. Not all segments of Anhui Anke Biotechnology (Group) Company., Limited experienced an increase in sales in 2018: sales of Raw Material Medicine fell 18.4% to 68.01 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Anhui Anke Biotechnology (Group) Company., Limited
  Stock Performance Chart for Anhui Anke Biotechnology (Group) Company., Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 15.05
(Figures in Chinese Renmimbi)
1 Week 0.7%   13 Weeks -6.9%  
4 Weeks -4.7%   52 Weeks -0.7%  
 
Anhui Anke Biotechnology (Group) Company., Limited Key Data:
  Ticker: 300009 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 1,461,550,203
(Year Ending Jan 2019).
Employees: 1,993
  Currency: Chinese Renmimbi Market Cap: 15,807,313,261
  Fiscal Yr Ends: December Shares Outstanding: 1,050,319,818
  Share Type: A Gu Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.